1.Primary diffuse large B-cell lymphoma of the bone marrow in a frail and elderly patient successfully treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone.
Pasquale NISCOLA ; Massimiliano PALOMBI ; Stefano FRATONI ; Alessio PERROTTI ; Paolo DE FABRITIIS
Blood Research 2013;48(4):296-297
No abstract available.
Aged*
;
B-Lymphocytes*
;
Bone Marrow*
;
Cyclophosphamide*
;
Doxorubicin*
;
Humans
;
Lymphoma, B-Cell*
;
Prednisone*
;
Vincristine*
;
Rituximab
2.Steroid-refractory immune thrombocytopenia in the era of the new thrombomimetic drugs: is there still a role for rituximab?.
Massimiliano PALOMBI ; Laura SCARAMUCCI ; Marco GIOVANNINI ; Malgorzata Monika TRAWINSKA ; Pasquale NISCOLA ; Paolo DE FABRITIIS
Blood Research 2016;51(1):66-66
No abstract available.
Thrombocytopenia*
;
Rituximab
3.Long-term survival of a patient with bone marrow gelatinous degeneration of idiopathic origin.
Pasquale NISCOLA ; Massimiliano PALOMBI ; Stefano FRATONI ; Malgorzata Monika TRAWINSKA ; Laura SCARAMUCCI ; Andrea TENDAS ; Marco GIOVANNINI ; Alessio PERROTTI ; Paolo DE FABRITIIS
Korean Journal of Hematology 2012;47(4):309-310
No abstract available.
Bone Marrow
;
Gelatin
;
Humans
Result Analysis
Print
Save
E-mail